Allison Stange lost 40 pounds since starting Zepbound in April 2024, improving both her blood pressure and sleep apnea. Now ...

Activist investor Glenview Capital is reducing its stake in healthcare giant CVS Health following its first-quarter earnings ...

CVS Health delivered first-quarter results that beat Wall Street expectations, but said its Aetna unit plans to withdraw next ...

Activist investor Glenview Capital Management sold 3.75 million shares of CVS Health Corp. and pledged to keep the rest, ...

CVS Health raised its full-year profit forecast on Thursday and said it plans to exit the market for Obamacare health ...

Oklahoma Attorney General joins three other states in filing a complaint against CVS Pharmacy. The complaint alleges the drugstore chain charged higher prices for prescriptions covered under Medicaid ...

Transitions of care—moving patients from one care site to another—continues to be a challenge in healthcare. | Startup Kouper ...

(Reuters) -Activist investor Glenview Capital said on Tuesday it reduced its holdings in CVS Health by 3.75 million shares ...

The complaint alleged that through a discount card program with ScriptSave, CVS customers who paid in cash received discounts ...

Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish ...

Eli Lilly won’t lose its grip on the weight loss market despite recent investor concerns. Meanwhile, Zocdoc releases an AI-powered scheduling assistant.

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.